NO943540D0 - Antiviral peptides - Google Patents

Antiviral peptides

Info

Publication number: NO943540D0
Authority: NO; Norway
Prior art keywords: antiviral peptides; antiviral; peptides
Prior art date: 1992-03-25

Application number

NO943540A

Other languages

Norwegian (no)

Other versions

NO943540L (en

Inventor

Colin William Greengrass

Stephen Derek Albert Street

Peter John Whittle

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-25

Filing date

1994-09-23

Publication date

1994-09-23

1992-03-25 Priority claimed from GB929206462A external-priority patent/GB9206462D0/en

1993-01-27 Priority claimed from GB939301638A external-priority patent/GB9301638D0/en

1994-09-23 Application filed by Pfizer filed Critical Pfizer

1994-09-23 Publication of NO943540D0 publication Critical patent/NO943540D0/en

1994-11-21 Publication of NO943540L publication Critical patent/NO943540L/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)

NO943540A 1992-03-25 1994-09-23 Antiviral peptides NO943540L (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB929206462A GB9206462D0 (en)	1992-03-25	1992-03-25	Antiviral peptides
GB939301638A GB9301638D0 (en)	1993-01-27	1993-01-27	Antiviral peptides
PCT/EP1993/000597 WO1993019059A1 (en)	1992-03-25	1993-03-13	Antiviral peptides

Publications (2)

Publication Number	Publication Date
NO943540D0 true NO943540D0 (en)	1994-09-23
NO943540L NO943540L (en)	1994-11-21

Family

ID=26300586

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO943540A NO943540L (en)	1992-03-25	1994-09-23	Antiviral peptides

Country Status (13)

Country	Link
EP (1)	EP0632808A1 (en)
JP (1)	JPH07501556A (en)
KR (1)	KR950700901A (en)
AU (1)	AU3748393A (en)
BR (1)	BR9306138A (en)
CA (1)	CA2131154A1 (en)
CZ (1)	CZ229594A3 (en)
FI (1)	FI944428A0 (en)
HU (1)	HU9402744D0 (en)
NO (1)	NO943540L (en)
RU (1)	RU94041225A (en)
SK (1)	SK114094A3 (en)
WO (1)	WO1993019059A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE143025T1 (en) *	1991-01-02	1996-10-15	Merrell Pharma Inc	ANTIVIRAL COMPOUNDS
HUT73411A (en) *	1993-07-08	1996-07-29	Merrell Dow Pharma	Difluoro statone analogs
DE69418050T2 (en) *	1993-09-09	1999-11-25	Merrell Pharmaceuticals Inc., Cincinnati	ANTIVIRAL ANALOGS OF DIFLUOROSTATON
US6114380A (en) *	1995-12-18	2000-09-05	Merrell Pharmaceuticals Inc.	Difluoro statone analogs
GB9601680D0 (en)	1996-01-27	1996-03-27	Pfizer Ltd	Therapeutic agents
CA2320233C (en) *	1998-02-02	2004-07-27	Lg Chemical Ltd.	Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
US6809200B2 (en)	2000-07-28	2004-10-26	Pfizer Inc.	Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
JP2008535876A (en)	2005-04-14	2008-09-04	エフ．ホフマン−ラロシュアーゲー	Aminopyrazole derivatives, their production and use as pharmaceutical formulations.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL91780A (en) *	1988-10-04	1995-08-31	Abbott Lab	Renin inhibiting hexanoic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them
IL92011A0 (en) *	1988-10-19	1990-07-12	Abbott Lab	Heterocyclic peptide renin inhibitors
CA2010531A1 (en) *	1989-03-06	1990-09-06	Werner Neidhart	Amino acid derivatives
WO1990012804A2 (en) *	1989-04-18	1990-11-01	The Upjohn Company	Peptides having novel polar n-terminal groups
DE4001236A1 (en) *	1990-01-18	1991-07-25	Bayer Ag	New oligopeptide(s) contg. 2-amino-2-methyl propionic acid residue - are antiviral agents for human or veterinary therapy including treatment of AIDS and ARC

1993
- 1993-03-13 CZ CZ942295A patent/CZ229594A3/en unknown
- 1993-03-13 EP EP93906535A patent/EP0632808A1/en not_active Withdrawn
- 1993-03-13 WO PCT/EP1993/000597 patent/WO1993019059A1/en not_active Application Discontinuation
- 1993-03-13 JP JP5516236A patent/JPH07501556A/en active Pending
- 1993-03-13 AU AU37483/93A patent/AU3748393A/en not_active Abandoned
- 1993-03-13 RU RU94041225/04A patent/RU94041225A/en unknown
- 1993-03-13 SK SK1140-94A patent/SK114094A3/en unknown
- 1993-03-13 CA CA002131154A patent/CA2131154A1/en not_active Abandoned
- 1993-03-13 BR BR9306138A patent/BR9306138A/en not_active Application Discontinuation
- 1993-03-13 HU HU9402744A patent/HU9402744D0/en unknown
1994
- 1994-09-23 NO NO943540A patent/NO943540L/en unknown
- 1994-09-23 FI FI944428A patent/FI944428A0/en unknown
- 1994-09-24 KR KR1019940703314A patent/KR950700901A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1993019059A1 (en)	1993-09-30
AU3748393A (en)	1993-10-21
RU94041225A (en)	1996-07-20
SK114094A3 (en)	1995-04-12
HU9402744D0 (en)	1994-12-28
CA2131154A1 (en)	1993-09-30
CZ229594A3 (en)	1995-04-12
KR950700901A (en)	1995-02-20
FI944428A (en)	1994-09-23
EP0632808A1 (en)	1995-01-11
JPH07501556A (en)	1995-02-16
FI944428A0 (en)	1994-09-23
BR9306138A (en)	1998-06-23
NO943540L (en)	1994-11-21

Publication	Publication Date	Title
NO942066D0 (en)	1994-06-03	peptide
DE69315842D1 (en)	1998-01-29	PEPTIDE COMPOUNDS
DE69325333D1 (en)	1999-07-22	Antiviral composition
ITMI931471A1 (en)	1995-01-07	SCI
AT399443B (en)	1995-05-26	SPORTSHOE
FI940109A0 (en)	1994-01-10	peptides
FI953127A0 (en)	1995-06-22	purine
FI944428A0 (en)	1994-09-23	Antiviral peptides
GB9210744D0 (en)	1992-07-08	Antiviral peptides
FI933150A (en)	1994-01-12	SKARVUTFORMNINGSANORDNING
NO932237L (en)	1993-12-20	Linear peptides
LV10286A (en)	1994-10-20	Peptide Compounds
ATA227792A (en)	1994-11-15	SPORTSHOE
LV10287A (en)	1994-10-20	Peptide Compounds
IL105099A0 (en)	1993-07-08	Antiviral peptides
KR940018006U (en)	1994-07-30	Jeonju Complete
KR940000399U (en)	1994-01-03	Ossuary complex
ITMI922963A0 (en)	1992-12-24	CYCLIC PEPTIDES
ITFE920014V0 (en)	1992-11-30	ENDOLANCET B
BR9200295A (en)	1993-07-20	AURISSIMA
ATA256392A (en)	1993-12-15	BANDROOM
BR9201149A (en)	1993-10-05	MUTLIMOVEL
BR9200298A (en)	1992-05-26	MICROSISTEN-TELESUPERVISAO
BR9200611A (en)	1993-08-17	HYDROCHOFRE
BR9200296A (en)	1993-07-27	VARRE-LAVA